GlaxoSmithKline's Big Bet: Tapping Our Body's Electronics

A few years ago, Moncef Slaoui, then GlaxoSmithKline's head of research, challenged his team to come up with a new pillar of medicine. The British drugmaker already makes traditional small-molecule pills and biologic therapies made with living cells, and it sells vaccines and consumer products. One area not yet tapped by medicine? The electrical signals that govern many of the functions in our bodies.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news